Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation
- PMID: 8168137
- DOI: 10.1016/0092-8674(94)90322-0
Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation
Abstract
Chronic myelomonocytic leukemia (CMML) is a myelodysplastic syndrome characterized by abnormal clonal myeloid proliferation and by progression to acute myelogenous leukemia (AML). CMML thus offers an opportunity to study early genetic events in the transition to AML. A recently recognized subgroup of CMML has a t(5;12)(q33;p13) balanced translocation. We report that the consequence of the t(5;12) translocation is expression of a fusion transcript in which the tyrosine kinase domain of the platelet-derived growth factor receptor beta (PDGFR beta) on chromosome 5 is coupled to a novel ets-like gene, tel, on chromosome 12. The tel-PDGFR beta fusion demonstrates the oncogenic potential of PDGFR beta and may provide a paradigm for early events in the pathogenesis of AML.
Similar articles
-
TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13).Blood. 1995 May 15;85(10):2848-52. Blood. 1995. PMID: 7742547
-
Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11.Oncogene. 1995 Apr 20;10(8):1511-9. Oncogene. 1995. PMID: 7731705
-
Involvement of the TEL gene in hematologic malignancy by diverse molecular genetic mechanisms.Curr Top Microbiol Immunol. 1996;211:279-88. doi: 10.1007/978-3-642-85232-9_28. Curr Top Microbiol Immunol. 1996. PMID: 8585959 Review. No abstract available.
-
Fusion of TEL/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute myelogenous leukemia with t(5;12)(q31;p13).Genes Chromosomes Cancer. 1999 Nov;26(3):192-202. doi: 10.1002/(sici)1098-2264(199911)26:3<192::aid-gcc2>3.0.co;2-e. Genes Chromosomes Cancer. 1999. PMID: 10502316
-
The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms.Curr Top Microbiol Immunol. 1997;220:67-79. doi: 10.1007/978-3-642-60479-9_5. Curr Top Microbiol Immunol. 1997. PMID: 9103676 Review. No abstract available.
Cited by
-
The Diverse Roles of ETV6 Alterations in B-Lymphoblastic Leukemia and Other Hematopoietic Cancers.Adv Exp Med Biol. 2024;1459:291-320. doi: 10.1007/978-3-031-62731-6_13. Adv Exp Med Biol. 2024. PMID: 39017849 Review.
-
ETV6::ABL1 positive myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (MLN-TK) with blast crisis treated with flumatinib mesylate.Ann Hematol. 2024 Sep;103(9):3801-3804. doi: 10.1007/s00277-024-05887-6. Epub 2024 Jul 12. Ann Hematol. 2024. PMID: 38992279
-
Tumour-reactive plasma cells in antitumour immunity: current insights and future prospects.Immunother Adv. 2024 Apr 25;4(1):ltae003. doi: 10.1093/immadv/ltae003. eCollection 2024. Immunother Adv. 2024. PMID: 38736973 Free PMC article. Review.
-
The unexpected and unresolved roles of PDGFRA and PDGFRB in T-cell acute lymphoblastic leukemia.Haematologica. 2024 Nov 1;109(11):3461-3462. doi: 10.3324/haematol.2023.284524. Haematologica. 2024. PMID: 38385300 Free PMC article. No abstract available.
-
Neotelomeres and Telomere-Spanning Chromosomal Arm Fusions in Cancer Genomes Revealed by Long-Read Sequencing.bioRxiv [Preprint]. 2023 Dec 1:2023.11.30.569101. doi: 10.1101/2023.11.30.569101. bioRxiv. 2023. Update in: Cell Genom. 2024 Jul 10;4(7):100588. doi: 10.1016/j.xgen.2024.100588 PMID: 38077026 Free PMC article. Updated. Preprint.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
